Prevalence of Preeclampsia in Hormozgan Province

Publish Year: 1393
نوع سند: مقاله ژورنالی
زبان: English
View: 40

This Paper With 5 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_HMJ-18-6_007

تاریخ نمایه سازی: 28 بهمن 1402

Abstract:

Introduction: Preeclampsia is a potentially life-threatening disease during pregnancy diagnosed by hypertension and proteinuria after ۲۰ weeks of gestation. The etiology and pathogenesis remain mysterious and poorly understood. It is a major cause of maternal and neonatal death and morbidity worldwide, affecting nearly ۵-۱۰% of all pregnancies. In this study we, aimed to determine the prevalence of preeclampsia in southern Iran, various districts of Hormozgan province, in order to outline existing high risk disease-areas headed for early diagnosis of the disease. Methods: A retrospective cross-sectional study was carried out on ۱۰۳۳ ethnic-matched unrelated pre-eclamptic subjects out of ۱۷۷۹۲ pregnant women who had delivery from September ۲۰۱۲ to March ۲۰۱۳ in Hormozgan province. Demographic and clinical features of the study subjects were collected using well-structured questionnaire. Statistical analysis was performed using SPSS. Chi-Square test was used and P<۰.۰۵ was considered statistically significant. Results: Preeclampsia prevalence was generally ۵.۸% in Hormozgan. ۴۱% and ۵۹% of pre-eclamptic women were nullipara and multipara, respectively. ۶۲% of the deliveries were done by Cesarian section. Individual frequency distribution of preeclampsia in each studied cities were ۱۸.۸% in Bandar Khamir, ۱۳.۷% in Bashagard, ۱۲.۱% in the province cities ranged from ۳.۱% in Kish to ۱۸.۸% in Bandar Khamir. Conclusion: Our study showed a similar frequency distribution as the world prevalence for pre-eclampsia. Early detection of high risk subjects for pre-eclampsia and subsequent perinatal care should be considered in some areas of the province. Planned intervention could manage and decrease the rate of pre-eclampsia and its complications effectively.